Natural flavonoid pectolinarigenin alleviated kidney fibrosis via inhibiting the activation of TGFβ/SMAD3 and JAK2/STAT3 signaling
- 1 February 2021
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 91, 107279
Abstract
No abstract availableKeywords
Funding Information
- Sichuan University (ZYGD18027)
- Key Research and Development Program of Sichuan Province
This publication has 29 references indexed in Scilit:
- Renal fibrosis: novel insights into mechanisms and therapeutic targetsNature Reviews Nephrology, 2010
- JAK/STAT signaling in renal diseasesKidney International, 2010
- A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathyKidney International, 2010
- Reduction of Stat3 Activity Attenuates HIV-Induced Kidney InjuryJournal of the American Society of Nephrology, 2009
- Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathyKidney International, 2009
- In vitro biological evaluation of novel 7-O-dialkylaminoalkyl cytotoxic pectolinarigenin derivatives against a panel of human cancer cell linesBioorganic & Medicinal Chemistry Letters, 2008
- Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-β1 productionOncogene, 2006
- Natural Products as Sources of New Drugs over the Period 1981−2002Journal of Natural Products, 2003
- Cross‐talk between IL‐6 and TGF‐β signaling in hepatoma cellsFEBS Letters, 2001
- Activation of Stat3 preassembled with platelet-derived growth factor β receptors requires Src kinase activityOncogene, 2000